To determine if our findings with Ror2 promoting aggressive features of tumor growth, cell migration, and cell invasion translated into promoting tumor progression in ccRCC patients, we turned to the recently published TCGA ccRCC dataset [25]. This evidence concerns the gene ROR2 and nonpapillary renal cell carcinoma.